PN-943
Protagonist Therapeutics, Inc.
[]
phd candidate ellis michiels will be presenting her results applying basescope analysis to gain deeper insights into the intratumor heterogeneity in pdac at this year's 2022 conference. catch her oral presentation discussing her research on 11 oct at 9:54 am 
InnoSer is a young and innovative CRO, supporting biomedical companies in the fields of oncology, neurodegenerative, cardiovascular, and kidney diseases.